title: Capecitabine and lapatinib treatment in head and neck cancer.
authors.forename: Vicki
authors.initials: V
authors.lastname: Brower
mesh_terms: D000069287:Capecitabine / Q000009:adverse effects / Q000627:therapeutic use*; D002945:Cisplatin / Q000009:adverse effects / Q000627:therapeutic use; D018572:Disease-Free Survival; D051766:Early Growth Response Protein 1 / Q000037:antagonists & inhibitors / Q000235:genetics; D051767:Early Growth Response Protein 2 / Q000037:antagonists & inhibitors / Q000235:genetics; D005472:Fluorouracil / Q000009:adverse effects / Q000627:therapeutic use; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D006801:Humans
chemical_list: C497325:EGR1 protein, human; C497326:EGR2 protein, human; D051766:Early Growth Response Protein 1; D051767:Early Growth Response Protein 2; D000069287:Capecitabine; D002945:Cisplatin; D005472:Fluorouracil